Keymed Biosciences (HKSE:02162) Days Payable : 1,466.06 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Keymed Biosciences Days Payable?

Keymed Biosciences's average Accounts Payable for the six months ended in Jun. 2024 was HK$32.31 Mil. Keymed Biosciences's Cost of Goods Sold for the six months ended in Jun. 2024 was HK$4.02 Mil. Hence, Keymed Biosciences's Days Payable for the six months ended in Jun. 2024 was 1,466.06.

The historical rank and industry rank for Keymed Biosciences's Days Payable or its related term are showing as below:

HKSE:02162' s Days Payable Range Over the Past 10 Years
Min: 64.65 Med: 221.27 Max: 1268.27
Current: 443.76

During the past 5 years, Keymed Biosciences's highest Days Payable was 1268.27. The lowest was 64.65. And the median was 221.27.

HKSE:02162's Days Payable is ranked better than
75.63% of 714 companies
in the Biotechnology industry
Industry Median: 127.14 vs HKSE:02162: 443.76

Keymed Biosciences's Days Payable increased from Jun. 2023 (299.53) to Jun. 2024 (1,466.06). It may suggest that Keymed Biosciences delayed paying its suppliers.

Keymed Biosciences Days Payable Historical Data

The historical data trend for Keymed Biosciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keymed Biosciences Days Payable Chart

Keymed Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

64.65

1,268.27

221.27

Keymed Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial					458.58	48,536.39	299.53	265.29	1,466.06

Competitive Comparison of Keymed Biosciences's Days Payable

For the Biotechnology subindustry, Keymed Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Keymed Biosciences's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keymed Biosciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Keymed Biosciences's Days Payable falls into.

Keymed Biosciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Keymed Biosciences's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (16.654	+	32.253)	/	2 )	/	40.337	*	365
=	24.4535					/	40.337	*	365
=	221.27

Keymed Biosciences's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (32.253	+	32.366)	/	2 )	/	4.022	*	365 / 2
=	32.3095					/	4.022	*	365 / 2
=	1,466.06

Keymed Biosciences Days Payable Related Terms

Thank you for viewing the detailed overview of Keymed Biosciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Keymed Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keymed Biosciences Inc (HKSE:02162) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219

Website

https://www.keymedbio.com

Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. Its clinical-stage drug candidates include CM310, CM326, CM313, and CM336 among others. The company is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it generates a majority of its revenue from overseas markets and the rest from Mainland China.

Executives

Chen Bo	2201 Interest of corporation controlled by you
Eagle Hero Management Limited	2101 Beneficial owner
Trident Trust Company (hk) Limited	2301 Trustee
Moonshot Holdings Limited	2101 Beneficial owner
Hh Kny Holdings Limited
Hillhouse Investment Management, Ltd.
Boyu Capital Group Holdings Ltd
Xyxy Holdings Ltd.
Tong Xiaomeng

Keymed Biosciences Headlines

No Headlines